Kyntra Bio Inc - Company Profile

Powered by

All the sales intelligence you need on Kyntra Bio Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Kyntra Bio Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Kyntra Bio Inc.

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Kyntra Bio Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Kyntra Bio Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

James A. Schoeneck

Chairman Executive Board Since: 2020 Age: 68

Mr James A. Schoeneck has been the Chairman of the company since 2020. Prior to this, he served as the Interim Chief Executive Officer of the company. Previously, He served as the Director at AnaptysBio Inc. He served as the Chief Executive Officer and Director at Depomed Inc. He served as the Chief Executive Officer at BrainCells Inc, ActivX BioSciences Inc and Prometheus Laboratories Inc. He also served as the Vice President and General Manager, Immunology at Janssen Biotech Inc.

Read Hide full bio of James A. Schoeneck

Thane Wettig

Director; Chief Executive Officer Executive Board Since: 2023 Age: 61

Mr. Thane Wettig has been the Chief Executive Officer of the company since 2023. Prior to this, he served as the Chief Commercial Officer of the company. Previously, he served as the Metabolic Franchise Head and Chief Commercial Officer at Intarcia Therapeutics. Prior to that, he served as the Vice President of Global Marketing, Strategy and Alliance Management at Lilly Diabetes.

Read Hide full bio of Thane Wettig

David DeLucia

Senior Vice President; Chief Financial Officer Senior Management Since: 2024 Age: 37

Mr. David DeLucia has been the Senior Vice President and Chief Financial Officer of the company since 2024. Prior to this, he served as Vice President and Head of Corporate Financial Planning and Analysis, Investor Relations, and Treasury of the company. Mr DeLucia held positions at TherapeuticsMD, overseeing Financial Planning and Analysis, Corporate Development, and Investor Relations.

Read Hide full bio of David DeLucia

Michelle Simonetti

Executive Director; Head - People and Culture Senior Management

Christine L. Chung

Senior Vice President - China Operations Senior Management Since: 2007 Age: 57
Gain a 360-degree view of Kyntra Bio Inc and make more informed decisions for your business Gain a 360-degree view of Kyntra Bio Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer